Braze Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Braze is expected to report Q2 EPS of $0.16, up from $0.15 a year earlier, on consensus revenue of $220.26 million versus $180.11 million last year, implying roughly 22% revenue growth. Ahead of the Sept. 8 post-close release, five analysts maintained bullish Buy/Overweight/Outperform ratings and raised price targets to $35-$40. Shares closed 3.9% lower at $31.96 Friday following mixed Q1 results.

Analysis

BRZE enters results with a more demanding setup than its modest pre-event sentiment suggests: recent target increases have likely shifted the relevant hurdle from a revenue beat to evidence that growth can reaccelerate without renewed sales-and-marketing intensity. For a customer-engagement platform, the highest-value indicators are net revenue retention, large-customer adds, remaining performance obligations and the implied next-quarter growth guide. A beat driven only by implementation timing or services mix would be lower quality and unlikely to support durable multiple expansion.

The key competitive read-through is whether enterprise consolidation favors BRZE's specialized engagement stack or whether bundled alternatives from Salesforce (CRM) and Twilio (TWLO) are winning budget scrutiny. Improving gross margin alongside stable retention would indicate scale benefits and support a rerating toward higher-growth SaaS peers over 6-18 months; deteriorating retention or a guide reliant on back-half assumptions would expose BRZE to a sharper de-rating because its valuation depends on sustained mid-20%-area growth rather than mature-software cash flow.

Consensus appears positioned for a clean execution quarter, making the asymmetric near-term risk a cautious outlook rather than a headline miss. Over the next 1-3 months, follow-through depends on whether management can demonstrate enterprise deal velocity and expansion demand despite AI-related product investment. The bullish thesis is falsified by sequential deterioration in cRPO/billings, net retention below management's prior operating range, or material operating-margin giveback; conversely, an acceleration in forward contracted revenue would make the current analyst-target cluster look conservative.

Key Decisions for Investors

• Maintain a tactical neutral-to-small long BRZE into the print only if position sizing assumes a guidance-driven gap risk; add on a post-results pullback if revenue guidance implies sustained growth above the current consensus trajectory and cRPO/billings accelerate. Target a 10-15% rerating over 1-3 months versus a 7-10% stop on weak forward guidance.
• Preferred relative-value expression: long BRZE / short CRM in equal sector-beta dollars after results if BRZE demonstrates improving retention and margin leverage. The trade isolates a potential specialized-platform share gain from broad enterprise-software multiple risk; exit if BRZE's forward-growth premium fails to improve within two reporting periods.
• Do not buy event options without verifying implied move, open interest and post-earnings liquidity. Establish an alert: if implied volatility prices a move materially below BRZE's prior four-quarter absolute post-earnings move, a defined-risk call spread is attractive only with confirmation of rising cRPO and constructive guidance.
• If management guides below consensus or cites elongated enterprise sales cycles, avoid averaging down immediately; use TWLO and CRM commentary in the following weeks to determine whether the issue is company-specific execution or a broader customer-engagement budget slowdown.